Mnl Nominees Limited (On Behalf Of Eos Innovation Fund) investment portfolio

Bioliberty Ltd creates a soft‑robotic glove together with a digital therapy platform that deliver grip assistance and hand‑rehabilitation therapy. The products are aimed at individuals with hand weakness caused by mobility‑limiting conditions or injuries.

Laverock Therapeutics builds a programmable gene‑silencing platform to engineer next‑generation cell and gene therapies, concentrating on disease‑responsive treatments for indications such as diabetes and solid‑tumour oncology. It serves biotech and pharmaceutical developers seeking advanced cell‑therapy solutions.